Unraveling the impact of common medications on biomarker patterns in Alzheimer's disease and mild cognitive impairment
{{output}}
Background: The aging global population faces significant challenges from Alzheimer's disease (AD). Metabolomics offers a non-invasive, cost-effective diagnostic alternative. Researchers identified significant variations in the ... ...
